Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of the Neurological Sciences|March 24, 2007
Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacyS Ozakbas, B B Akdede, G Kösehasanogullari, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2004
Utilization of the auditory consonant trigram test to screen for cognitive impairment in patients with multiple sclerosis: comparison with the paced auditory serial addition testS Ozakbas, B Ormeci, B B Kivircik Akdede, et al.Tissue Antigens|September 5, 2006
Development of multiple sclerosis after vaccination against hepatitis B: a study based on human leucocyte antigen haplotypesS Ozakbas, E Idiman, B Yulug, et al.Acta Neurologica Belgica|April 26, 2024
Feasibility of exergaming for upper extremity rehabilitation in people with multiple sclerosis: prospective clinical trialA T Ozdogar, M Emec, E Kaya, et al.Clinical Neurology and Neurosurgery|March 2, 2024
Cognition as a parameter in monitoring the effect of multiple sclerosis relapse treatment: A prospective controlled studyB Piri Cinar, C Baba, S Demir, et al.Multiple Sclerosis and Related Disorders|May 3, 2021
The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?S Sen, R Karabudak, I Schiavetti, et al.Journal of Medical Economics|December 12, 2023
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United KingdomT Spelman, W L Herring, C Acosta, et al.BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.Pageof 1